The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Simulation Modeling as a Decision-Making Aid in Economic Evaluation for Randomized Clinical Trials
Abstract
This chapter reports on the use of simulation in supporting decision-making about what data to collect in a randomized clinical trial (RCT). We show how simulation also allows the identification of critical variables in the RCT by measuring their effects on the simulation model’s “behavior.” Healthcare systems pose many of the challenges, including difficulty in understanding the system being studied, uncertainty over which data to collect, and problems of communication between problem owners. In this chapter we show how simulation also allows the identification of critical variables in the RCT by measuring their effects on the simulation model’s “behavior.” The experience of developing the simulation model leads us to suggest simple but extremely valuable lessons. The first relates to the inclusion of stakeholders in the modeling process and the accessibility of the resulting models. The ownership and confidence felt by stakeholders in our case is, we feel, extremely important and may provide an example to others developing models.
Related Content
|
Julia Zimmer, Elisa Degenkolbe, Britt Wildemann, Petra Seemann.
© 2013.
30 pages.
|
|
George I. Lambrou, Maria Adamaki, Apostolos Zaravinos.
© 2013.
22 pages.
|
|
Svetoslav Nikolov, Mukhtar Ullah, Momchil Nenov, Julio Vera Gonzalez, Peter Raasch, Olaf Wolkenhauer.
© 2013.
23 pages.
|
|
Ana M. Sotoca, Michael Weber, Everardus J. J. van Zoelen.
© 2013.
19 pages.
|
|
Franz Ricklefs, Sonja Schrepfer.
© 2013.
16 pages.
|
|
Sonja Schallenberg, Cathleen Petzold, Julia Riewaldt, Karsten Kretschmer.
© 2013.
25 pages.
|
|
Ali Mobasheri.
© 2013.
32 pages.
|
|
|